By Colin Kellaher

 

Danaher Corp.'s Beckman Coulter unit on Monday said its Access SARS-CoV-2 IgG assay received U.S. Food & Drug Administration emergency-use authorization.

Beckman Coulter said it has already shipped tests to more than 400 hospitals, clinics and diagnostics laboratories in the U.S., and that it has begun distribution of the new antibody tests globally.

The company said it is able to deliver more than 30 million tests a month.

Beckman Coulter said the test, which detects IgG antibodies directed to the receptor binding domain of the spike protein of the novel coronavirus, has shown 100% positive percent agreement and 99.6% negative percent agreement, significantly reducing the risk for false positives.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

June 29, 2020 08:31 ET (12:31 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Danaher (NYSE:DHR)
Historical Stock Chart
From Jul 2020 to Aug 2020 Click Here for more Danaher Charts.
Danaher (NYSE:DHR)
Historical Stock Chart
From Aug 2019 to Aug 2020 Click Here for more Danaher Charts.